Pfizer transfers certain medicines to Mylan as part of an agreement
The consideration for the medicines in India is valued at Rs 180.48 crore
The consideration for the medicines in India is valued at Rs 180.48 crore
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
It is the first branded generic alternative to Fostair 100/6 pMDI
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The group has a total of 320 ANDA approvals
The company has tied up with OrbiMed as a financial partner for global reach
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
Subscribe To Our Newsletter & Stay Updated